Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Phar­ma has a mes­sage to in­vestors about the re­sults of the first round of drug price ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act: It’s fine. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA